Literature DB >> 30727900

Evaluating the Relationship Between Serum Level of Interleukin-6 and Rheumatoid Arthritis Severity and Disease Activity.

Elham Rajaei1, Karim Mowla1, Qodratollah Hayati1, Ali Ghorbani2, Mehrdad Dargahi-Malamir1, Saeed Hesam3, Zeinab Deris Zayeri1.   

Abstract

AIM: The aim of this study was to evaluate the relationship between Interleukin-6 (IL-6) serum level and the severity and activity of Rheumatoid Arthritis (RA).
METHODS: In this cross-sectional study, 120 RA patients referred to the rheumatology clinic, the patients were diagnosed by rheumatologists according to ACR / EULAR 2010 criteria. Based on DAS28 score the patients were divided into 4 groups: Remission, Mild, Moderate and Severe. Each group contained 30 patients. Serum levels of Erythrocyte Sedimentation Rate (ESR), C-Reactive Protein (CRP), anti-Cyclic Citrullinated Peptide (anti-CCP) and Rheumatoid Factor (RF) and serum levels of IL-6, were measured. The relationship between these factors was measured and compared to the relationship between IL-6 and these factors, and the activity of the disease was evaluated based on DAS-28.
RESULTS: This study showed that the serum level of IL-6 has a significant relationship with RA activity according to DAS-28 (P value <0.001). There is also a significant relationship between the ESR level, the number of painful joints, and the number of swollen joints, and the severity of the disease based on VAS.
CONCLUSION: Generally the findings of this study indicate that serum level of IL-6 plays an important role in the severity and activity of RA disease and can be considered as a determining factor in evaluating the severity of RA in RA patients and it is a good guide for a step up or down of treatment. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  DAS-28; Interleukin 6; cardiomyocytes; cytokine; glycoprotein; rheumatoid arthritis

Mesh:

Substances:

Year:  2020        PMID: 30727900     DOI: 10.2174/1573397115666190206144223

Source DB:  PubMed          Journal:  Curr Rheumatol Rev        ISSN: 1573-3971


  5 in total

1.  Network Pharmacology Analysis and Experimental Validation to Investigate the Mechanism of Total Flavonoids of Rhizoma Drynariae in Treating Rheumatoid Arthritis.

Authors:  Guang-Yao Chen; Jing Luo; Yi Liu; Xin-Bo Yu; Xiao-Yu Liu; Qing-Wen Tao
Journal:  Drug Des Devel Ther       Date:  2022-06-08       Impact factor: 4.319

2.  Could IL-1β, IL-6, IFN-γ, and sP-selectin serum levels be considered as objective and quantifiable markers of rheumatoid arthritis severity and activity?

Authors:  Olga M Koper-Lenkiewicz; Ewa Gińdzieńska-Sieśkiewicz; Joanna Kamińska; Anna J Milewska; Otylia Kowal-Bielecka; Joanna Matowicka-Karna
Journal:  Reumatologia       Date:  2022-02-28

3.  Urban Particulate Matter Enhances ROS/IL-6/COX-II Production by Inhibiting MicroRNA-137 in Synovial Fibroblast of Rheumatoid Arthritis.

Authors:  Ming-Horng Tsai; Miao-Ching Chi; Jen-Fu Hsu; I-Ta Lee; Ko-Ming Lin; Mei-Ling Fang; Ming-Hsueh Lee; Chiang-Wen Lee; Ju-Fang Liu
Journal:  Cells       Date:  2020-06-02       Impact factor: 6.600

4.  Endogenous stimulation is responsible for the high frequency of IL-17A-producing neutrophils in patients with rheumatoid arthritis.

Authors:  Maria Gonzalez-Orozco; Rosa E Barbosa-Cobos; Paola Santana-Sanchez; Lizbeth Becerril-Mendoza; Leonardo Limon-Camacho; Ana I Juarez-Estrada; Gustavo E Lugo-Zamudio; Jose Moreno-Rodriguez; Vianney Ortiz-Navarrete
Journal:  Allergy Asthma Clin Immunol       Date:  2019-08-01       Impact factor: 3.406

5.  Molecular characterisation of the synovial fluid microbiome in rheumatoid arthritis patients and healthy control subjects.

Authors:  Dargham Bayan Mohsen Hammad; Veranja Liyanapathirana; Daniel Paul Tonge
Journal:  PLoS One       Date:  2019-11-21       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.